Medtronic plc (BVMF:MDTC34)

Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of BRL 643.37 billion. The enterprise value is 744.74 billion.

Market Cap	643.37B
Enterprise Value	744.74B

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	Dec 23, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	86.93%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 26.36 and the forward PE ratio is 16.42.

PE Ratio	26.36
Forward PE	16.42
PS Ratio	3.43
PB Ratio	2.47
P/TBV Ratio	n/a
P/FCF Ratio	22.48
P/OCF Ratio	16.69
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.90, with an EV/FCF ratio of 26.02.

EV / Earnings	30.51
EV / Sales	4.09
EV / EBITDA	14.90
EV / EBIT	21.89
EV / FCF	26.02

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.57.

Current Ratio	2.54
Quick Ratio	1.55
Debt / Equity	0.57
Debt / EBITDA	2.88
Debt / FCF	5.19
Interest Coverage	9.30

Financial Efficiency

Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 7.98%.

Return on Equity (ROE)	9.39%
Return on Assets (ROA)	4.57%
Return on Invested Capital (ROIC)	7.98%
Return on Capital Employed (ROCE)	8.09%
Weighted Average Cost of Capital (WACC)	7.06%
Revenue Per Employee	1.98M
Profits Per Employee	256,925
Employee Count	95,000
Asset Turnover	0.39
Inventory Turnover	2.07

Taxes

In the past 12 months, Medtronic has paid 4.88 billion in taxes.

Income Tax	4.88B
Effective Tax Rate	16.59%

Stock Price Statistics

The stock price has decreased by -4.93% in the last 52 weeks. The beta is 0.72, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-4.93%
50-Day Moving Average	257.32
200-Day Moving Average	241.68
Relative Strength Index (RSI)	39.35
Average Volume (20 Days)	96

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.32

Income Statement

In the last 12 months, Medtronic had revenue of BRL 187.75 billion and earned 24.41 billion in profits. Earnings per share was 18.94.

Revenue	187.75B
Gross Profit	122.34B
Operating Income	35.08B
Pretax Income	29.43B
Net Income	24.41B
EBITDA	49.95B
EBIT	35.08B
Earnings Per Share (EPS)	18.94

Balance Sheet

The company has 44.36 billion in cash and 148.53 billion in debt, with a net cash position of -103.41 billion.

Cash & Cash Equivalents	44.36B
Total Debt	148.53B
Net Cash	-103.41B
Net Cash Per Share	n/a
Equity (Book Value)	260.30B
Book Value Per Share	201.96
Working Capital	77.12B

Cash Flow

In the last 12 months, operating cash flow was 38.55 billion and capital expenditures -9.92 billion, giving a free cash flow of 28.62 billion.

Operating Cash Flow	38.55B
Capital Expenditures	-9.92B
Free Cash Flow	28.62B
FCF Per Share	n/a

Margins

Gross margin is 65.16%, with operating and profit margins of 18.68% and 13.00%.

Gross Margin	65.16%
Operating Margin	18.68%
Pretax Margin	15.67%
Profit Margin	13.00%
EBITDA Margin	26.60%
EBIT Margin	18.68%
FCF Margin	15.25%

Dividends & Yields

This stock pays an annual dividend of 5.68, which amounts to a dividend yield of 2.29%.

Dividend Per Share	5.68
Dividend Yield	2.29%
Dividend Growth (YoY)	0.43%
Years of Dividend Growth	2
Payout Ratio	78.65%
Buyback Yield	0.83%
Shareholder Yield	3.12%
Earnings Yield	3.79%
FCF Yield	4.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	6